Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Goat Polyclonal Anti-CD45 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 1,260 aa to the C-terminus of human CD45 produced in E. coli. |
Goat Anti-APOL1 Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-NNNYKILQADQE, from the C Terminus of the protein sequence according to NP_003652.2; NP_663318.1. |
Goat Polyclonal Anti-CD19 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 510 aa to the C-terminus of human CD19 produced in E. coli. |
Goat Polyclonal Anti-VEGFR2 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from the N-terminus (residues 20-125 aa) of human VEGFR2 produced in E. coli. |
Goat Anti-CACNA1C Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-RARGRPSEEELQD, from the C Terminus of the protein sequence according to NP_000710.5. |
Goat Polyclonal Anti-CD4 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within 50 to 235 aa, corresponding to the external domain of human CD4 produced in E. coli. |
Goat Polyclonal Antibody against ABCC8
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-EFDKPEKLLSRKD, from the C Terminus of the protein sequence according to NP_000343.2. |
Goat Polyclonal Anti-CD31 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide within residues 690 aa to the C-terminus of human CD31 produced in E. coli. |
Goat Anti-CD20 / MS4A1 (C Terminus) Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence CQDQESSPIENDSSP, from the C Terminus of the protein sequence according to NP_068769.2; NP_690605.1. |
Goat Anti-GRIK3 / GLUR7 Antibody
| Applications | WB |
| Reactivities | Rat, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-KIRQLPIDSDDSRP, from the internal region of the protein sequence according to NP_000822.2. |
Goat Polyclonal Anti-CDH1 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified Recombinant peptide derived from within residues 601 to 701 of human CDH1 produced in E. coli. |
Goat Anti-NOX1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-DKATDIVTGLKQK, from the internal region of the protein sequence according to NP_008983.2; NP_39249.1. |
TGFBI Goat Polyclonal (Internal) Antibody
| Applications | IHC |
| Reactivities | Bat, Gibbon, Bovine, Dog, Gorilla, Horse, Human, Mouse, Pig, Rabbit, Rat |
| Conjugation | Unconjugated |
| Immunogen | TGFBI antibody was raised against synthetic peptide C-QLYTDRTEKLRPE from an internal region of human TGFBI (NP_000349.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Mouse, Rat, Elephant, Panda, Bovine, Dog, Bat, Horse, Rabbit, Pig, Opossum (100%); Marmoset, Platypus (92%). |
Goat Polyclonal Anti-CB1 (isoform a) Antibody
| Applications | WB |
| Reactivities | Human, Mouse (Expected from sequence similarity: Rat, Dog, Cow) |
| Conjugation | Unconjugated |
| Immunogen | The immunogen for Anti-CB1 (isoform a) Antibody: Peptide with sequence SNDIQYEDIKGDMAS-C, from the N Terminus of the protein sequence according to NP_057167.2. |
Goat Polyclonal Antibody against Tafazzin
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-HLKTQAEQLHNH, from the C Terminus of the protein sequence according to NP_000107.1; NP_851828.1; NP_851829.1; NP_851830.1. |
Goat Polyclonal Antibody against NGFR
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-AKREEVEKLLNG, from the internal region of the protein sequence according to NP_002498.1. |
Goat Anti-TMPRSS4 Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence DSTRCNADDAYQGE, from the internal region of the protein sequence according to NP_063947.1; NP_001077416.1. |
Goat Anti-Ramp1 (C-Term., mouse) Antibody
| Applications | WB |
| Reactivities | Rat |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-DYQSKRTEGIV, from the C-Terminus of the protein sequence according to NP_058590.1; NP_848488.2. |
Goat Anti-ADRA2A Antibody
| Reactivities | Mouse |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-TERRPNGLGPERS, from the internal region of the protein sequence according to NP_000672.2. |
PKD1 / Polycystin Goat Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Gorilla, Gibbon |
| Conjugation | Unconjugated |
| Immunogen | PKD1 / Polycystin antibody was raised against synthetic peptide C-RTPLRAKNKVHP from the C-terminus of human PKD1 (NP_001009944.1; NP_000287.2). Percent identity by BLAST analysis: Human, Gorilla, Gibbon (100%); Marmoset, Panda, Cat, Dog, Horse (83%). |
Goat Polyclonal Antibody against Caveolin 1
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-DELSEKQVYDAH, from the internal region of the protein sequence according to NP_001744.2. |
Goat Polyclonal Antibody against TUSC3
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence PQRQCSVCRQAN, from the internal region of the protein sequence according to NP_006756.2; NP_839952.1. |
BNPI / VGLUT1 Goat Polyclonal Antibody
| Applications | IHC |
| Reactivities | Gibbon, Gorilla, Human |
| Conjugation | Unconjugated |
| Immunogen | SLC17A7 / BNPI / VGLUT1 antibody was raised against synthetic peptide C-HDQLAGSDDSEMED from an internal region of human SLC17A7 / VGLUT1 (NP_064705.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Elephant (100%); Marmoset, Mouse, Rat, Panda, Bovine, Rabbit, Pig (93%); Hamster, Dog, Horse (86%). |
Goat Polyclonal Antibody against MC2R
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence ENINNTARNNSDC, from the N Terminus of the protein sequence according to NP_000520.1. |
Goat Anti-SNX19 Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-TTSASDTPGNSKR, from the internal region of the protein sequence according to NP_055573.2. |
Goat Anti-UNC5C Antibody
| Applications | IF |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence NCTVSEEPTGID, from the internal region of the protein sequence according to NP_003719.2. |
Goat Anti-cardiolipin synthase 1 Polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Peptide with sequence C-RSALGSALDPLADK, from the internal region of the protein sequence according to NP_061968.1; NP_001120930.1. |
Active filters
Category
- Antibodies
Antibody Hosts
- Goat
Families
- Transmembrane
Availabilities
- In Stock
Filter by
Target Symbol
- CANX (3)
- CDH11 (3)
- GJA1 (3)
- CAV1 (2)
- CD19 (2)
- CD63 (2)
- CDH1 (2)
- PTPRC (2)
- ABCB5 (1)
- ABCC4 (1)
- ABCC5 (1)
- ABCC8 (1)
- ADRA2A (1)
- AGTR1 (1)
- APOL1 (1)
- ATP6AP2 (1)
- B3GNT2 (1)
- BAK1 (1)
- BAX (1)
- BDKRB1 (1)
- BMPR1A (1)
- BOC (1)
- CACNA1C (1)
- CAV2 (1)
- CAV3 (1)
- CD2 (1)
- CD4 (1)
- CDH2 (1)
- CHRM1 (1)
- CHRNA5 (1)
- CNR1 (1)
- COMT (1)
- CPT1C (1)
- CRLS1 (1)
- CYBB (1)
- DGAT1 (1)
- DNAJB9 (1)
- EGFR (1)
- ENPEP (1)
- ERBB2 (1)
- F2R (1)
- FFAR1 (1)
- FLVCR1 (1)
- FZD7 (1)
- FZD8 (1)
- GCNT3 (1)
- GLP1R (1)
- GPM6A (1)
- GPR119 (1)
- GRIA4 (1)
- GRIK3 (1)
- HRH1 (1)
- INSR (1)
- ITGAM (1)
- KDR (1)
- LAT (1)
- MAOB (1)
- MC2R (1)
- MOG (1)
- MS4A1 (1)
- NGFR (1)
- NOX1 (1)
- NRG3 (1)
- PECAM1 (1)
- PKD1 (1)
- PMEL (1)
- RAMP1 (1)
- SCNN1G (1)
- SLC17A7 (1)
- SLC22A17 (1)
- SLC25A47 (1)
- SLC26A6 (1)
- SLC4A11 (1)
- SMO (1)
- SNX19 (1)
- STX6 (1)
- TAZ (1)
- TGFBI (1)
- TMPRSS4 (1)
- TNF (1)
- TNFRSF14 (1)
- TNFSF14 (1)
- TUSC3 (1)
- UNC5C (1)
- VANGL2 (1)
- WNT4 (1)
Reactivities
Isotypes
Clonalities
Conjugates
Pathways
- Neuroactive ligand-receptor interaction (11)
- Cell adhesion molecules (CAMs) (9)
- Pathways in cancer (9)
- Calcium signaling pathway (8)
- Cytokine-cytokine receptor interaction (7)
- Focal adhesion (7)
- Hematopoietic cell lineage (7)
- Metabolic pathways (7)
- Adherens junction (5)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (5)
- Primary immunodeficiency (5)
- Regulation of actin cytoskeleton (5)
- T cell receptor signaling pathway (5)
- ABC transporters (4)
- Antigen processing and presentation (4)
- Basal cell carcinoma (4)
- Bladder cancer (4)
- Colorectal cancer (4)
- Endometrial cancer (4)
- Gap junction (4)
- Leukocyte transendothelial migration (4)
- Type II diabetes mellitus (4)
- Wnt signaling pathway (4)
- Endocytosis (3)
- ErbB signaling pathway (3)
- Fc gamma R-mediated phagocytosis (3)
- MAPK signaling pathway (3)
- Melanogenesis (3)
- Melanoma (3)
- Vascular smooth muscle contraction (3)
- Adipocytokine signaling pathway (2)
- Alzheimer's disease (2)
- Amyotrophic lateral sclerosis (ALS) (2)
- Apoptosis (2)
- B cell receptor signaling pathway (2)
- Complement and coagulation cascades (2)
- Dilated cardiomyopathy (2)
- Fc epsilon RI signaling pathway (2)
- GnRH signaling pathway (2)
- Hedgehog signaling pathway (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Lysosome (2)
- Natural killer cell mediated cytotoxicity (2)
- Neurotrophin signaling pathway (2)
- Non-small cell lung cancer (2)
- Pancreatic cancer (2)
- Pathogenic Escherichia coli infection (2)
- Prostate cancer (2)
- Renin-angiotensin system (2)
- TGF-beta signaling pathway (2)
- Thyroid cancer (2)
- Tyrosine metabolism (2)
- Viral myocarditis (2)
- Allograft rejection (1)
- Arginine and proline metabolism (1)
- Asthma (1)
- Axon guidance (1)
- Cardiac muscle contraction (1)
- Dorso-ventral axis formation (1)
- Drug metabolism - cytochrome P450 (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- Fatty acid metabolism (1)
- Glioma (1)
- Glycerolipid metabolism (1)
- Glycerophospholipid metabolism (1)
- Glycine (1)
- Glycosphingolipid biosynthesis - lacto and neolacto series (1)
- Graft-versus-host disease (1)
- Histidine metabolism (1)
- Huntington's disease (1)
- Insulin signaling pathway (1)
- Keratan sulfate biosynthesis (1)
- Long-term potentiation (1)
- N-Glycan biosynthesis (1)
- NOD-like receptor signaling pathway (1)
- O-Glycan biosynthesis (1)
- PPAR signaling pathway (1)
- Phenylalanine metabolism (1)
- Prion diseases (1)
- RIG-I-like receptor signaling pathway (1)
- Retinol metabolism (1)
- SNARE interactions in vesicular transport (1)
- Systemic lupus erythematosus (1)
- Taste transduction (1)
- Toll-like receptor signaling pathway (1)
- Tryptophan metabolism (1)
- Type I diabetes mellitus (1)
- VEGF signaling pathway (1)
- p53 signaling pathway (1)
- serine and threonine metabolism (1)